Cellosaurus logo
expasy logo

Cellosaurus CHLA-122 (CVCL_A054)

[Text version]
Cell line name CHLA-122
Accession CVCL_A054
Resource Identification Initiative To cite this cell line use: CHLA-122 (RRID:CVCL_A054)
Disease Neuroblastoma (NCIt: C3270)
Neuroblastoma (ORDO: Orphanet_635)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Originate from same individual CVCL_6590 ! CHLA-136
Sex of cell Female
Age at sampling 3Y
Category Cancer cell line
STR profile Source(s): COG; PubMed=20922763

Markers:
AmelogeninX
CSF1PO10,11
D2S133823,25
D3S135815,18
D5S8189,12
D7S8208
D8S117910,13
D13S3178,11
D16S5399
D18S5112,18
D19S43313,14
D21S1131.2,32.2
FGA23,25
TH017,9
TPOX8,11
vWA16,17

Run an STR similarity search on this cell line
Web pages Provider; CCR; -; https://www.cccells.org/dl/NB_Data_Sheets/CHLA-122_Cell_Line_Data_Sheet_COGcell_org.pdf
Publications

PubMed=11507071
Nino Keshelava, Juan J. Zuo, Ping Chen, Sitara N. Waidyaratne, Marian C. Luna, Charles Joseph Gomer, Timothy J. Triche, Charles Patrick Reynolds;
Loss of p53 function confers high-level multidrug resistance in neuroblastoma cell lines.
Cancer Res. 61:6185-6193(2001)

PubMed=20922763; DOI=10.1002/pbc.22801; PMCID=PMC3005554
Min H. Kang, Malcolm A. Smith, Christopher L. Morton, Nino Keshelava, Peter J. Houghton, Charles Patrick Reynolds;
National Cancer Institute pediatric preclinical testing program: model description for in vitro cytotoxicity testing.
Pediatr. Blood Cancer 56:239-249(2011)

PubMed=24792489; DOI=10.1007/s11060-014-1456-8
Ahsan S. Farooqi, Rebecca A. Dagg, L. Mi Rim Choi, Jerry W. Shay, Charles Patrick Reynolds, Loretta M.S. Lau;
Alternative lengthening of telomeres in neuroblastoma cell lines is associated with a lack of MYCN genomic amplification and with p53 pathway aberrations.
J. Neurooncol. 119:17-26(2014)

Cross-references
Encyclopedic resources Wikidata; Q54812155
Entry history
Entry creation06-Jun-2012
Last entry update10-Apr-2025
Version number13